These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
826 related articles for article (PubMed ID: 31665154)
1. Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia. Woldeyohannes D; Assefa T; Aman R; Tekalegn Y; Hailemariam Z PLoS One; 2019; 14(10):e0224025. PubMed ID: 31665154 [TBL] [Abstract][Full Text] [Related]
2. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia. Hamusse SD; Teshome D; Hussen MS; Demissie M; Lindtjørn B BMC Public Health; 2016 Jul; 16():593. PubMed ID: 27430266 [TBL] [Abstract][Full Text] [Related]
3. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study. Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076 [TBL] [Abstract][Full Text] [Related]
4. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia. Shibabaw A; Gelaw B; Wang SH; Tessema B PLoS One; 2018; 13(6):e0198080. PubMed ID: 29944658 [TBL] [Abstract][Full Text] [Related]
5. Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia. Alene KA; Viney K; McBryde ES; Tsegaye AT; Clements AC Trop Med Int Health; 2017 Mar; 22(3):351-362. PubMed ID: 27978594 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia. Desissa F; Workineh T; Beyene T BMC Public Health; 2018 Apr; 18(1):422. PubMed ID: 29606112 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State. Mulu W; Mekonnen D; Yimer M; Admassu A; Abera B Afr Health Sci; 2015 Jun; 15(2):368-77. PubMed ID: 26124781 [TBL] [Abstract][Full Text] [Related]
8. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia. Mekonnen F; Tessema B; Moges F; Gelaw A; Eshetie S; Kumera G BMC Infect Dis; 2015 Oct; 15():461. PubMed ID: 26503269 [TBL] [Abstract][Full Text] [Related]
9. Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China. Alene KA; Yi H; Viney K; McBryde ES; Yang K; Bai L; Gray DJ; Clements ACA; Xu Z BMC Infect Dis; 2017 Aug; 17(1):573. PubMed ID: 28814276 [TBL] [Abstract][Full Text] [Related]
11. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis. Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336 [TBL] [Abstract][Full Text] [Related]
12. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia. Adane K; Ameni G; Bekele S; Abebe M; Aseffa A BMC Public Health; 2015 Jun; 15():572. PubMed ID: 26092570 [TBL] [Abstract][Full Text] [Related]
14. Survival status and its predictors among multi-drug resistance tuberculosis treated patients in Ethiopia: Multicenter observational study. Bade AB; Mega TA PLoS One; 2020; 15(11):e0241684. PubMed ID: 33166299 [TBL] [Abstract][Full Text] [Related]
15. Intensive phase treatment outcome and associated factors among patients treated for multi drug resistant tuberculosis in Ethiopia: a retrospective cohort study. Molie T; Teklemariam Z; Klinkenberg E; Dessie Y; Kumsa A; Mohammed H; Debebe A; Assefa D; Habte A; Bedru A; Fiseha D; Seyoum B BMC Infect Dis; 2019 Sep; 19(1):818. PubMed ID: 31533644 [TBL] [Abstract][Full Text] [Related]
16. Predictors of mortality and loss to follow-up among drug resistant tuberculosis patients in Oromia Hospitals, Ethiopia: A retrospective follow-up study. Woldeyohannes D; Tekalegn Y; Sahiledengle B; Assefa T; Aman R; Hailemariam Z; Mwanri L; Girma A PLoS One; 2021; 16(5):e0250804. PubMed ID: 33956812 [TBL] [Abstract][Full Text] [Related]
17. Determinants of sputum culture conversion time in multidrug-resistant tuberculosis patients in ALERT comprehensive specialized hospital, Addis Ababa, Ethiopia: A retrospective cohort study. Abebe M; Atnafu A; Tilahun M; Sero N; Neway S; Alemu M; Tesfaye G; Mihret A; Bobosha K; Wan C PLoS One; 2024; 19(5):e0304507. PubMed ID: 38820260 [TBL] [Abstract][Full Text] [Related]
18. Surveillance of drug resistance tuberculosis based on reference laboratory data in Ethiopia. Diriba G; Kebede A; Tola HH; Alemu A; Tadesse M; Tesfaye E; Mehamed Z; Meaza A; Yenew B; Molalign H; Dagne B; Sinshaw W; Amare M; Moga S; Abebaw Y; Sied G Infect Dis Poverty; 2019 Jun; 8(1):54. PubMed ID: 31200748 [TBL] [Abstract][Full Text] [Related]
19. Multidrug-resistant Mycobacterium tuberculosis and associated risk factors in Oromia Region of Ethiopia. Mulisa G; Workneh T; Hordofa N; Suaudi M; Abebe G; Jarso G Int J Infect Dis; 2015 Oct; 39():57-61. PubMed ID: 26327121 [TBL] [Abstract][Full Text] [Related]
20. Risk factors for multidrug-resistant tuberculosis in northwest Ethiopia: A case-control study. Alene KA; Viney K; McBryde ES; Gray DJ; Melku M; Clements ACA Transbound Emerg Dis; 2019 Jul; 66(4):1611-1618. PubMed ID: 30924283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]